Broad Institute of MIT and Harvard, Alphabet company Verily, and Microsoft entered a strategic partnership to accelerate new innovations in biomedicine through the Terra platform. Terra, originally created by Verily and the Broad Institute of MIT and Harvard, is a scalable, open-source platform for biomedical researchers to access data, run analysis tools and collaborate.
The new SARS-CoV-2 variant, known as B.1.1.7,is probably already in Massachusetts, says Dr. Eric Rosenberg, an infectious disease doctor and director of the clinical microbiology lab at Massachusetts General Hospital. If it's not, he says, it very soon will be.
New Delhi, Researchers at Indian Institute of Technology (IIT), Guwahati, claim to have found important clues to understand the death of massive stars and have also revealed the problems with the existing models. The research in collaboration with Max Planck Institute for Physics, Munich, Germany, and Northwestern University, USA, has also been published in international journal Physical Review Letters (PRL).
We're used to formal clothing expensive hotels and meeting venues that solitary confinement cells look spacious, with the offer of $20 coffees (if spending a minimum of $100), but this year, things are very different.
NEW YORK - The 39 th Annual JP Morgan Global Healthcare Conference kicked off on Monday, but instead of the usual crush of investors and presenters in the Westin St. Francis Hotel in San Francisco, this year the conference was held completely online due to the ongoing coronavirus pandemic.
WASHINGTON, Jan. 12, 2021 /PRNewswire/ -- The Institute for Portfolio Alternatives (IPA) today announced the election of Anne-Marie Vandenberg as chair-elect for 2021. Vandenberg currently serves as president, chief operating officer and portfolio manager of DWS's RREEF Property Trust.
If the spring semester of 2020 was a sprint in the face of COVID-19, the rest of the year was a marathon-or maybe a triathlon, as Tufts responded to a global pandemic unparalleled in recent history. In March, Tufts quickly brought coursework online, closed residence halls, paused most laboratory research, and halted non-emergency clinical services.
A buzzy Cambridge, Massachusetts biotech is advancing its research on a gene-editing treatment for heart disease. Verve Therapeutics CEO Sekar Kathiresan outlined the company's three-stage strategy to ultimately cure heart disease. Verve's first treatment candidate uses a next-generation gene-editing tool called base-editing to change a single letter in a person's genetic code.
Precision health is an approach to wellness that takes into account variability in genes, environment, and lifestyle for each person. And thanks to advancements in technology, it's here today. Huge amounts of data are being collected and analyzed to manage our care, with data sources including laboratory tests, biometric sensors, patient records, hospital data, and more.
Multiyear partnership brings together advanced technology, industry expertise and scale to help researchers interpret an unprecedented amount of biomedical data and derive insights to advance the treatment of human diseases CAMBRIDGE, Mass., SOUTH SAN FRANCISCO, Calif., and REDMOND, Wash. - Jan. 11, 2021 - On Monday, Broad Institute of MIT and Harvard, Verily, an Alphabet [...]
NEW YORK, NY (Jan. 11, 2021)--A new study has found that up to 20% of glioblastomas--an aggressive brain cancer--are fueled by overactive mitochondria and may be treatable with drugs currently in clinical trials. Mitochondria are responsible for creating the energy that fuels all cells.
Universities are preparing for an increase in COVID-19 cases by applying lessons learned from the fall, but a Colorado expert said the state is in a much different place now than it was in the fall when virus cases were lower.
HARTFORD, Conn.--()--The Travelers Institute, the public policy division of The Travelers Companies, Inc. (NYSE: TRV), today announced the lineup of its 2021 educational webinars, which will focus on critical issues facing customers and businesses. Topics will include the rollout of COVID-19 vaccines, hiring and workforce strategies, the future of insuring autonomous vehicles and geopolitical hot spots.
LONDON -- Trials have begun in London for the next generation of COVID-19 vaccines with the first dose for a new nasal vaccine being developed by the U.S. company Codagenix having been administered at a quarantine facility in London, it was announced Monday morning.
As a science writer in 2020, one might wish to never write about COVID-related matters ever again. Just as you might never want to read about them. Here are some and intriguing health and medicine stories from the year that seemed all about a virus. Plenty good things were happening.
Parler, the alternative social media platform favored by conservatives, now finds itself virtually homeless on the internet as Amazon, Apple and Google have all booted it from their platforms in a span of a little more than 24 hours.
There's also broad bipartisan support about who should pay their fair share to support it: billionaires. According to the Institute for Policy Studies, the combined wealth of America's billionaires has increased by more than $1 trillion during the pandemic. Poll after poll shows overwhelming support for raising taxes on this group, who got a huge tax cut under Trump.
Read more about Nasal Covid-19 vaccine can be potential gamechanger, say experts on Business Standard. Public health experts believe that intranasal vaccines for coronavirus, administered through nose rather than muscles, can be a potential gamechanger in Indias fight against the coronavirus pandemic.
A LITTLE BEFORE 6 p.m. on Tuesday, Liz Ruark started out from the small Worcester County town of Harvard on the 30-mile drive to Kendall Square in Cambridge. Nestled on the floor of the backseat of her Subaru Forester was a Home Goods tote bag whose contents were key to the community's goal of keeping(...)
The Smithsonian Institute, which manages the world largest set of museums and research facilities, is looking to hire a new digital transformation lead to work on the virtual experience at Smithsonian's physical locations and online.